TrialJAMA dermatology2019

Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma.

Abdulaali R Almutairi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.